Healthcare news
Breaking news, regulatory updates, FDA / EMA / WHO / national health ministry announcements.
- nih
Clinical trial finds no difference in fluid treatment options for pediatric sepsis
NIH-supported study is largest ever to compare fluid interventions to prevent major kidney damage in children treated for septic shock.
- nih
Symptom-based approach treats opioid withdrawal in newborns with minimal drug exposure
NIH-funded clinical trial shows that the new approach could also decrease time in the hospital.
- nih
Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking
Clinical trial suggests semaglutide may help patients with alcohol use disorder and obesity.
- nih
Oral small-molecule GLP-1 drugs penetrate deep into the brain to suppress cravings
NIH-funded research identifies new mechanism of action for next-generation weight-loss drugs.
- nih
NIH-funded study suggests that testosterone suppresses brain tumor growth in males
Findings may warrant exploration of the hormones as glioblastoma treatment.
- nih
Researchers develop innovative model for risk assessment for hypertrophic cardiomyopathy
NIH-funded study incorporates new measures to better predict outcomes in chronic heart condition.
- nih
NIH-funded study maps human pancreatic islet cells, offering new clues to diabetes risk
Comprehensive characterization of islet cells facilitated by national organ donation program.
- nih
Researchers identify first suite of human antibodies against measles virus
NIH-funded study lays foundation for antibody-based measles treatment.
- nih
NIH-supported project expands access to care for children with amblyopia
Open-access tool guides eye doctors without specific pediatric eye care training in amblyopia diagnosis and management.
- nih
NIH researchers identify avenue for enhanced GLP-1-induced weight loss
Modulating intracellular signaling may extend drug effects.
- WHO
Seventy-ninth World Health Assembly – Daily update: 23 May 2026
Summary of discussions of 23 May at the Seventy-ninth World Health Assembly.
- FDA
Newly Added Guidance Documents
Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.
- WHO
Seventy-ninth World Health Assembly – Daily update: 22 May 2026
Summary of discussions of 22 May at the Seventy-ninth World Health Assembly.
- FDA
M11 Clinical Electronic Structured Harmonised Protocol
M11 Clinical Electronic Structured Harmonised Protocol
- FDA
Generic Drug User Fee Amendments
This page features news and information for industry and stakeholders about GDUFA, its fee structure, payment methods, and related information.
- cdc
Raaw Energy Expands Recall of Dog Food Because of Listeria Monocytogenes Health Risk
Raaw Energy is voluntarily notifying the public of a recall involving products produced between 7/17/25 and 12/23/25 due to possible Listeria contamination. Another batch date is 3.31.26 Beef and Turkey Medley. While not all products from this period tested positive, this action is being taken out
- FDA
BsUFA IV: Fiscal Years 2028-2032
On September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.
- FDA
FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
Today, the U.S. Food and Drug Administration approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis (advanced liver scarring) or with compensated cirrhosis.
- FDA
Untitled Letters
These letters are supplied by the CDER Freedom of Information Office and only cover Office of Prescription Drug Promotion's untitled letters. FDA may have redacted or edited some of the letters to remove confidential information.
- FDA
Generic Drug Facilities, Sites and Organization Lists
Generic Drug Facilities, Sites and Organization Lists
- cdc
SKS Copack Recalls Various Specialty Beverages Because of Possible Health Risk
SKS Copack of Cerritos, CA is recalling various specialty beverages, because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy per
- FDA
First Generic Drug Approvals
Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for pati
- FDA
2025 First Generic Drug Approvals
2025 First Generic Drug Approvals
- FDA
HIV Treatment
Get information about drugs approved to treat HIV
- WHO
First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda 2026 – Temporary recommendations
The Committee’s advice aligned with the determination by the WHO Director-General that the event constitutes a public health emergency of international concern (PHEIC), but does not meet the criteria for pandemic emergency. The DG, considering the advice of the Committee, he is hereby issuing the following temporary recommendations to all States Parties.